Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

377.73
Delayed Data
As of 3:59pm ET
 +17.09 / +4.74%
Today’s Change
348.96
Today|||52-Week Range
605.93
-30.42%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 480.50, with a high estimate of 668.00 and a low estimate of 325.00. The median estimate represents a +27.21% increase from the last price of 377.73.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.65
Sales
$1.2B
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.37%
 
 
 
 
 
 
Growthannually -2.61%
 
 
 
 
 
 

Sales

Growthquarterly 7.40%
 
 
 
 
 
 
Growthannually 23.70%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.